DBV Technologies joins the Euronext Tech Leaders index

DBV Technologies, a biopharmaceutical company, has announced its inclusion in the Euronext Tech Leaders index, effective June 22, 2026. This inclusion underscores the company's growth and innovation in the biotechnology sector. The index comprises over 100 European companies, offering increased visibility to institutional investors.

CEO Daniel Tassé expressed his pride in joining this prestigious group. He emphasized that this recognition reflects the progress made with the VIASKIN® Peanut patch, a potential treatment for children with peanut allergies. This integration could offer new opportunities for the company, which is already listed on Euronext Paris and Nasdaq.